Compare VIR & ROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | ROG |
|---|---|---|
| Founded | 2016 | 1832 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2019 | 1994 |
| Metric | VIR | ROG |
|---|---|---|
| Price | $9.36 | $138.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $19.43 | ★ $133.00 |
| AVG Volume (30 Days) | ★ 1.6M | 228.1K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | $68,556,000.00 | ★ $879,091,000.00 |
| Revenue This Year | $270.22 | $7.64 |
| Revenue Next Year | N/A | $6.09 |
| P/E Ratio | ★ N/A | $546.75 |
| Revenue Growth | N/A | ★ 7.07 |
| 52 Week Low | $4.16 | $61.17 |
| 52 Week High | $11.66 | $144.46 |
| Indicator | VIR | ROG |
|---|---|---|
| Relative Strength Index (RSI) | 43.07 | 71.24 |
| Support Level | $8.47 | $77.11 |
| Resistance Level | $10.29 | N/A |
| Average True Range (ATR) | 0.47 | 5.97 |
| MACD | -0.16 | 0.62 |
| Stochastic Oscillator | 8.48 | 80.19 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.